Ann Lab Med.  2018 Jul;38(4):289-290. 10.3343/alm.2018.38.4.289.

Mac-2 Binding Protein Glycosylation Isomer: Emerging Non-Invasive Serum Marker for Liver Fibrosis

Affiliations
  • 1Department of Laboratory Medicine, School of Medicine, Kyung Hee University Hospital, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea.
  • 2Department of Laboratory Medicine, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea.

Abstract

No abstract available.


MeSH Terms

Biomarkers*
Carrier Proteins*
Glycosylation*
Liver Cirrhosis*
Liver*
Biomarkers
Carrier Proteins

Cited by  1 articles

Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer
Mina Hur, Mikyoung Park, Hee-Won Moon, Won Hyeok Choe, Chae Hoon Lee
Ann Lab Med. 2022;42(2):249-257.    doi: 10.3343/alm.2022.42.2.249.


Reference

1. Narimatsu H. Development of M2BPGi: a novel fibrosis serum glycobiomarker for chronic hepatitis/cirrhosis diagnostics. Expert Rev Proteomics. 2015; 12:683–693. PMID: 26394846.
2. Cho SY, Lee HJ, Kim JW, Park TS. Mean platelet volume and mean platelet volume/platelet count ratio in patients with chronic alcohol consumption. Platelets. 2015; 26:371–372. PMID: 24617309.
3. Moon HW, Park M, Hur M, Kim H, Choe WH, Yun YM. Usefulness of enhanced liver fibrosis, glycosylation isomer of Mac-2 binding protein, galectin-3, and soluble suppression of tumorigenicity 2 for assessing liver fibrosis in chronic liver diseases. Ann Lab Med. 2018; 38:331–337. PMID: 29611383.
4. Lambrecht J, Verhulst S, Mannaerts I, Reynaert H, van Grunsven LA. Prospects in non-invasive assessment of liver fibrosis: liquid biopsy as the future gold standard. Biochim Biophys Acta. 2018; 1864:1024–1036. PMID: 29329986.
5. Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018; 1. 09. DOI: 10.1007/s00535-017-1425-z. [Epub ahead of print].
6. Atsukawa M, Tsubota A, Okubo T, Arai T, Nakagawa A, Itokawa N, et al. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein. Hepatol Res. 2017; 12. 23. DOI: 10.1111/hepr.13046. [Epub ahead of print].
7. Jekarl DW, Choi H, Lee S, Kwon JH, Lee SW, Yu H, et al. Diagnosis of liver fibrosis with Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) among chronic hepatitis B patients. Ann Lab Med. 2018; 38:348–354. PMID: 29611385.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr